We found that ARPC5 was evidently positively associated with Immune scores in 22 cancers, and related to Stromal scores in 15 cancer types, suggesting ARPC5 might be a critical driver of immune cells and stromal cells. This evidence concerns the gene ARPC5 and cancer.